How was the year 2022 in research and development at our faculty?
Take a look at what the year 2022 brought in the field of research and development at the Faculty of Medicine MU. What awaits us in 2023? Take a short look back at the past year.
The research of Nicola Silva´s team from the Department of Biology, Faculty of Medicine is primarily focused on studying different aspects of meiotic chromosome segregation, emphasizing the mechanisms that ensure faithful DNA repair.
In meiotic cells, a wave of DNA double-strand breaks is physiologically induced at meiosis onset to allow homologous recombination to take place. This in turn, elicits the formation of crossovers, which are essential for the correct partitioning of the genetic material in the haploid gametes.
Under normal conditions, a strong homologous bias ensures that meiotic breaks are repaired in a conservative and error-free fashion. However, upon perturbed regulation of DNA repair mechanisms, meiotic DSBs can be hijacked by multiple illegitimate repair pathways, which can produce toxic outcomes.
The latest research of Nicola Silva´s lab found that the combined action of two important genes involved in DNA repair, the poly(ADP-ribose) eraser PARG and the E3 ubiquitin ligase BRCA1, is essential to regulate DNA repair pathway choice during meiosis, ensuring accurate chromosome segregation.
The latest research of Nicola Silva´s lab found that the combined action of two important genes involved in DNA repair, the poly(ADP-ribose) eraser PARG and the E3 ubiquitin ligase BRCA1, is essential to regulate DNA repair pathway choice during meiosis, ensuring accurate chromosome segregation.
Mutations in BRCA1 in humans are causative of breast/ovarian cancer susceptibility. In recent years, it has been discovered that abolishing ADP-ribosylation in BRCA1-mutated cells confers high levels of cancer cells death, which is currently exploited with high success in therapy. However, over time resistance mechanisms ensue, which render treatment less effective.
The research outcomes demonstrate that preventing ADP-ribosylation removal in BRCA1-mutated worms by abrogating PARG function causes high levels of embryonic lethality and impairs DNA repair, highlighting PARG as a putative target for future cancer therapy applications. In mammalian models, this type of research has been hindered in vivo by the embryonic lethality observed in mice when BRCA1 or PARG are mutated, further emphasizing how the use of simpler metazoan models can be instrumental to human health.
The latest results have recently been published in the prestigious journal Nucleic Acids Research
Take a look at what the year 2022 brought in the field of research and development at the Faculty of Medicine MU. What awaits us in 2023? Take a short look back at the past year.
The City of Brno has once again supported young scientists. 18 of the winners of the Brno Ph.D. Talent are students of Masaryk University, 4 of them are studying in doctoral programmes at the Faculty of Medicine.